Genetic analysis, in silico prediction, and family segregation in long QT syndrome

European Journal of Human Genetics

Volumn 23, Issue 1, 2015, Pages 79-85

  Riuró, Helena ^a   Campuzano, Oscar ^a   Berne, Paola ^b   Arbelo, Elena ^b   Iglesias, Anna ^a   Pérez Serra, Alexandra ^a   Coll Vidal, Mònica ^a,c   Partemi, Sara ^c   Mademont Soler, Irene ^a   Picó, Ferran ^a   Allegue, Catarina ^a   Oliva, Antonio ^c   Gerstenfeld, Edward ^d   Sarquella Brugada, Georgia ^e   Castro Urda, Víctor ^f   Fernández Lozano, Ignacio ^f   Mont, Lluís ^b   Brugada, Josep ^b   Scornik, Fabiana S ^a   Brugada, Ramon ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HOSPITAL SANT JOAN DE DÉU   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG; POTASSIUM CHANNEL KCNQ; VOLTAGE GATED SODIUM CHANNEL;

ADULT; ARTICLE; CLINICAL DECISION MAKING; COMPUTER MODEL; DISEASE SEVERITY; DNA SEQUENCE; ELECTROCARDIOGRAM; FAINTNESS; FAMILY HISTORY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; QT PROLONGATION; SEGREGATION ANALYSIS; ADOLESCENT; BIOLOGY; GENETIC SCREENING; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; PEDIGREE; YOUNG ADULT;

ADOLESCENT; ADULT; COMPUTATIONAL BIOLOGY; FEMALE; GENETIC TESTING; GENOTYPE; HUMANS; KCNQ POTASSIUM CHANNELS; LONG QT SYNDROME; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; VOLTAGE-GATED SODIUM CHANNELS; YOUNG ADULT;

EID: 84927058938     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.54     Document Type: Article

References (39)

1. Schwartz PJ, Stramba-Badiale M, Crotti L et al: Prevalence of the congenital long-QT syndrome. Circulation 2009; 120: 1761-1767.
2. Crotti L, Celano G, Dagradi F, Schwartz PJ: Congenital long QT syndrome. Orphanet J Rare Dis 2008; 3: 18.
3. Goldenberg I, Moss AJ: Long QT syndrome. J AmColl Cardiol 2008; 51: 2291-2300.
4. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS: Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88: 782-784.
5. Roden DM: Clinical practice. Long-QT syndrome. N Engl J Med 2008; 358: 169-176.
6. Wang Q, Curran ME, Splawski I et al: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12: 17-23.
7. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT: Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 1997; 17: 338-340.
8. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT: A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80: 795-803.
9. Abbott GW, Sesti F, Splawski I et al: MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97: 175-187.
10. Wang Q, Shen J, Splawski I et al: SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805-811.
11. Napolitano C, Priori SG, Schwartz PJ et al: Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005; 294: 2975-2980.
12. Splawski I, Shen J, Timothy KW et al: Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102: 1178-1185.
13. Tester DJ, Will ML, Haglund CM, Ackerman MJ: Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 507-517.
14. Kapplinger JD, Tester DJ, Salisbury BA et al: Spectrum and prevalence of mutations from the first 2500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009; 6: 1297-1303.
15. Hedley PL, Jorgensen P, Schlamowitz S et al: The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009; 30: 1486-1511.
16. Stattin EL, Bostrom IM, Winbo A et al: Founder mutations characterise the mutation panorama in 200 Swedish index cases referred for Long QT syndrome genetic testing. BMC Cardiovasc Disord 2012; 12: 95.
17. Schwartz PJ, Ackerman MJ, George Jr AL, Wilde AA: Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013; 62: 169-180.
18. Kauferstein S, Kiehne N, Erkapic D et al: A novel mutation in the cardiac ryanodine receptor gene (RyR2) in a patient with an unequivocal LQTS. Int J Cardiol 2011; 146: 249-250.
19. Zipes DP, Camm AJ, Borggrefe M et al: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e385-e484.
20. Gollob MH, Blier L, Brugada R et al: Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol 2011; 27: 232-245.
21. Moss AJ, Zareba W, Kaufman ES et al: Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 2002; 105: 794-799.
22. Priori SG, Schwartz PJ, Napolitano C et al: Risk stratification in the long-QT syndrome. N Engl J Med 2003; 348: 1866-1874.
23. Kapa S, Tester DJ, Salisbury BA et al: Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009; 120: 1752-1760.
24. Refsgaard L, Holst AG, Sadjadieh G, Haunso S, Nielsen JB, Olesen MS: High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet 2012; 20: 905-908.
25. Giudicessi JR, Ackerman MJ: Genetic testing in heritable cardiac arrhythmia syndromes: differentiating pathogenic mutations from background genetic noise. Curr Opin Cardiol 2013; 28: 63-71.
26. Gonzalez-Perez A, Lopez-Bigas N: Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 2011; 88: 440-449.
27. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP: Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7: e46688.
28. Giudicessi JR, Kapplinger JD, Tester DJ et al: Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circ Cardiovasc Genet 2012; 5: 519-528.
29. Kapplinger JD, Tester DJ, Alders M et al: An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010; 7: 33-46.
30. Hu D, Barajas-Martinez H, Nesterenko VV et al: Dual variation in SCN5A and CACNB2b underlies the development of cardiac conduction disease without Brugada syndrome. Pacing Clin Electrophysiol 2010; 33: 274-285.
31. Nishio Y, Makiyama T, Itoh H et al: D85N, a KCNE1 polymorphism, is a diseasecausing gene variant in long QT syndrome. J Am Coll Cardiol 2009; 54: 812-819.
32. Yoshikane Y, Yoshinaga M, Hamamoto K, Hirose S: A case of long QT syndrome with triple gene abnormalities: Digenic mutations in KCNH2 and SCN5A and gene variant in KCNE1. Heart Rhythm 2012; 10: 600-603.
33. Marjamaa A, Newton-Cheh C, Porthan K et al: Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med 2009; 265: 448-458.
34. Rivero A, Curtis AB: Sex differences in arrhythmias. Curr Opin Cardiol 2010; 25: 8-15.
35. Schwartz PJ, Priori SG, Spazzolini C et al: Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103: 89-95.
36. Frousios K, Iliopoulos CS, Schlitt T, Simpson MA: Predicting the functional consequences of non-synonymous DNA sequence variants-evaluation of bioinformatics tools and development of a consensus strategy. Genomics 2013; 102: 223-228.
37. Giudicessi JR, Ackerman MJ: Genotype- and phenotype-guided management of congenital long QT syndrome. Curr Probl Cardiol 2013; 38: 417-455.
38. Giudicessi JR, Ackerman MJ: Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes. Transl Res 2013; 161: 1-14.
39. Clancy CE, Kass RS: Defective cardiac ion channels: from mutations to clinical syndromes. J Clin Investig 2002; 110: 1075-1077.